Loading…
CardiaCare provides a non-invasive, wrist-worn neuromodulation therapy for atrial fibrillation that uses closed-loop monitoring and machine learning to reduce AF burden and symptoms. The system combines optical and ECG sensors, a smartphone app, and a cloud-based health platform to generate personalized median and ulnar nerve stimulation (mVNS) therapy aimed at immediate arrhythmia relief and lower recurrence after cardioversion or ablation. Marketed as a home-care solution, CardiaCare leverages a health cloud with more than 250 million cardiovascular data points to optimize care, with testimonials noting fewer AF episodes and improved quality of life.
AI named CardiaCare in March 2026.